- Your move, Roche: what next for crenezumab in Alzheimer's?
- What to look out for at the Alzheimer's Association International Conference
- Biomarker study raises hopes for Alzheimer's blood test
- Gantenerumab fails; time for Roche to cut its Alzheimer's losses?
COMMENT Other Informa Comment
- PROFILE: AstraZeneca's Mene Pangalos on yin and yang, not believing your own press, and his part in Soriot's vision
- Profile: Janssen R&D boss on the next big thing in medicine & 'ice bucket' funding